Differential localization and function of antibodyforming cells responsive to inactivated or liveattenuated influenza virus vaccines

International Immunology

Volumn 25, Issue 3, 2013, Pages 183-195

  Sealy, Robert ^a   Webby, Richard J ^a,b   Crumpton, Jeri C ^a   Hurwitz, Julia L ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antibody forming cells; Bone marrow; Cold adapted vaccine; Inactivated vaccine; Influenza virus; Upper and lower respiratory tract

Indexed keywords

IMMUNOGLOBULIN A; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL ACTIVITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCING CELL; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN;

ADOLESCENT; ADULT; ANIMALS; ANTIBODY-PRODUCING CELLS; ANTIGENS, VIRAL; CELL MOVEMENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFLUENZA VACCINES; MIDDLE AGED; SIGMODONTINAE; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 84876478101     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs107     Document Type: Article

References (51)

1. Thompson, W. W., Shay, D. K., Weintraub, E.,et al. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 289:179.
2. Dushoff, J., Plotkin, J. B., Viboud, C., Earn, D. J. and Simonsen, L. 2006. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am. J. Epidemiol. 163:181.
3. Taubenberger, J. K. and Kash, J. C. 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440.
4. Fraaij, P. L., Bodewes, R., Osterhaus, A. D. and Rimmelzwaan, G. F. 2011. The ins and outs of universal childhood influenza vaccination. Future Microbiol. 6:1171.
5. Vesikari, T., Karvonen, A., Korhonen, T., et al. 2006. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine. Pediatr. Infect. Dis. J. 25:590.
6. Ortiz, J. R., Sotomayor, V., Uez, O. C., et al. 2009. Strategy to enhance influenza surveillance worldwide. Emerg. Infect. Dis. 15:1271.
7. Rudraraju, R., Surman, S., Jones, B., Sealy, R., Woodland, D. L. and Hurwitz, J. L. 2011. Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut. Virology 410:429.
8. Sealy, R., Jones, B. G., Surman, S. L. and Hurwitz, J. L. 2010. Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Vaccine 28:6749.
9. Ottolini, M. G., Blanco, J. C., Eichelberger, M. C., et al. 2005. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J. Gen. Virol. 86:2823.
10. Eichelberger, M. C. 2007. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol. 20:243.
11. Davis, S. S. 2001. Nasal vaccines. Adv. Drug Deliv. Rev. 51:21.
12. Asanuma, H., Thompson, A. H., Iwasaki, T., et al. 1997. Isolation and characterization of mouse nasal-associated lymphoid tissue. J. Immunol. Methods 202:123.
13. Frey, S. E., Bernstein, D. I., Gerber, M. A., et al. 2012. Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. J. Infect. Dis 206:828.
14. Madhun, A. S., Akselsen, P. E., Sjursen, H., et al. 2010. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 29:266.
15. Belshe, R. B., Gruber, W. C., Mendelman, P. M., et al. 2000. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 181:1133.
16. Belshe, R. B., Mendelman, P. M., Treanor, J., et al. 1998. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med. 338:1405.
17. Glezen, W. P. 2008. Universal influenza vaccination and live attenuated influenza vaccination of children. Pediatr. Infect. Dis. J. 27(10 Suppl):S104.
18. Huber, V. C., Kleimeyer, L. H. and McCullers, J. A. 2008. Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine 26:5381.
19. Smith, H. and Sweet, C. 1988. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 10:56.
20. Hyland, L., Sangster, M., Sealy, R. and Coleclough, C. 1994. Respiratory virus infection of mice provokes a permanent humoral immune response. J. Virol. 68:6083.
21. Ahmed, R. 2003. Understanding immunological memory to improve vaccination strategies. Keystone Meeting Presentation: HIV Vaccine Development: Immunological and Biological Challenges, Banff Canada.
22. Slifka, M. K., Matloubian, M. and Ahmed, R. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895.
23. Jones, B., Zhan, X., Mishin, V., et al. 2009. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. Vaccine 27:1848.
24. Mora, J. R., Bono, M. R., Manjunath, N., et al. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424:88.
25. Sealy, R., Surman, S., Hurwitz, J. L. and Coleclough, C. 2003. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens. Immunology 108:431.
26. Cassani, B., Villablanca, E. J., De Calisto, J., Wang, S. and Mora, J. R. 2012. Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol. Aspects Med. 33:63.
27. Gray, D. 2002. A role for antigen in the maintenance of immunological memory. Nat. Rev. Immunol. 2:60.
28. Prince, G. A., Horswood, R. L. and Chanock, R. M. 1985. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol. 55:517.
29. Stensballe, L. G., Ravn, H., Kristensen, K., Meakins, T., Aaby, P. and Simoes, E. A. 2009. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J. Pediatr. 154:296.
30. Takamura, S., Roberts, A. D., Jelley-Gibbs, D. M., Wittmer, S. T., Kohlmeier, J. E. and Woodland, D. L. 2010. The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen. J. Exp. Med. 207:1153.
31. Tamura, S., Funato, H., Hirabayashi, Y., et al. 1991. Crossprotection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur. J. Immunol. 21:1337.
32. Mazanec, M. B., Lamm, M. E., Lyn, D., Portner, A. and Nedrud, J. G. 1992. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 23:1.
33. Renegar, K. B. and Small, P. A. Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972.
34. Israel, E. J., Taylor, S., Wu, Z., et al. 1997. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92:69.
35. Amanna, I. J., Slifka, M. K. and Crotty, S. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211:320.
36. Kataoka, K., Fujihashi, K., Terao, Y., et al. 2011. Oralnasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells. PLoS. ONE. 6:e25396.
37. Kaminski, D. A. and Stavnezer, J. 2006. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J. Immunol. 177:6025.
38. Sangster, M. Y., Riberdy, J. M., Gonzalez, M., Topham, D. J., Baumgarth, N. and Doherty, P. C. 2003. An early CD4+ T celldependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198:1011.
39. Gearhart, P. J., Hurwitz, J. L. and Cebra, J. J. 1980. Successive switching of antibody isotypes expressed within the lines of a B-cell clone. Proc. Natl. Acad. Sci. U.S.A. 77:5424.
40. Hurwitz, J. L., Tagart, V. B., Schweitzer, P. A. and Cebra, J. J. 1982. Patterns of isotype expression by B cell clones responding to thymus-dependent and thymus-independent antigens in vitro. Eur. J. Immunol. 12:342.
41. Lutzker, S., Rothman, P., Pollock, R., Coffman, R. and Alt, F. W. 1988. Mitogen- and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switching. Cell 53:177.
42. Amanna, I. J., Carlson, N. E. and Slifka, M. K. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357:1903.
43. Slifka, M. K., Antia, R., Whitmire, J. K. and Ahmed, R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363.
44. Benton, K. A., Misplon, J. A., Lo, C. Y., Brutkiewicz, R. R., Prasad, S. A. and Epstein, S. L. 2001. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J. Immunol. 166:7437.
45. Wiley, J. A., Hogan, R. J., Woodland, D. L. and Harmsen, A. G. 2001. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167:3293.
46. Kast, W. M., Roux, L., Curren, J., et al. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. U. S. A. 88:2283.
47. Brown, D. M., Dilzer, A. M., Meents, D. L. and Swain, S. L. 2006. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 177:2888.
48. Surman, S. L., Brown, S. A., Jones, B. G., Woodland, D. L. and Hurwitz, J. L. 2010. Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin. Aids Res Hum Retroviruses. 26:783.
49. McCullers, J. A. and Huber, V. C. 2012. Correlates of vaccine protection from influenza and its complications. Hum. Vaccin. Immunother. 8:34.
50. Belshe, R. B., Edwards, K. M., Vesikari, T., et al. 2007. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356:685.
51. Hoft, D. F., Babusis, E., Worku, S. et al. 2011. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 204:845.